Cargando…
Longitudinal effects of menopausal hormone treatments on platelet characteristics and cell-derived microvesicles
Activated platelets serve as a catalyst for thrombin generation and a source of vasoactive and mitogenic factors affecting vascular remodeling. Oral menopausal hormone treatments (MHT) may carry greater thrombotic risk than transdermal products. This study compared effects of oral and transdermal MH...
Autores principales: | Miller, Virginia M., Lahr, Brian D., Bailey, Kent R., Heit, John A., Harman, S. Mitchell, Jayachandran, Muthuvel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Informa Healthcare
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4732432/ https://www.ncbi.nlm.nih.gov/pubmed/25856160 http://dx.doi.org/10.3109/09537104.2015.1023273 |
Ejemplares similares
-
Alterations in Platelet Function and Cell-Derived Microvesicles in Recently Menopausal Women: Relationship to Metabolic Syndrome and Atherogenic Risk
por: Jayachandran, Muthuvel, et al.
Publicado: (2011) -
Differential effects of oral and transdermal menopausal hormone therapy on prostacyclin and thromboxane in platelets
por: Raz, Limor, et al.
Publicado: (2014) -
Menopausal hormone therapy, blood thrombogenicity, and development of white matter hyperintensities in women of the Kronos Early Estrogen Prevention Study
por: Jayachandran, Muthuvel, et al.
Publicado: (2020) -
Changes in carotid artery intima-media thickness 3 years after cessation of menopausal hormone therapy: follow-up from the Kronos Early Estrogen Prevention Study
por: Miller, Virginia M., et al.
Publicado: (2019) -
Leukocyte- and Platelet-Derived Microvesicle Interactions following In Vitro and In Vivo Activation of Toll-Like Receptor 4 by Lipopolysaccharide
por: Xiong, Jing, et al.
Publicado: (2011)